Article

Low-dose aspirin for the prevention of preeclampsia in nulliparous pregnant women -a prospective study at a tertiary care hospital

Author : Neeraja P, Ramadevi E, Chandana Loke

Background: Preeclampsia is a hypertensive disorder specific to pregnancy that remains a significant cause of maternal and neonatal morbidity and mortality. Low dose aspirin has been reported to reduce the incidence of preeclampsia. Aims and Objectives: To determine whether treatment with aspirin reduces the incidence of preeclampsia among nulliparous pregnant women. Materials and Methods: Our prospective study included 100 nulliparous, 13 to 25 weeks pregnant women. The total sample (n=100) was divided randomly in to two groups: Group A (n=50) received aspirin (60 mg plus starch) and Group B (n=50) received placebo (lactose plus starch). Measured variables were hypertension, preeclampsia, intrauterine fetal growth retardation and abruptio placentae. The observed data was tabulated and analyzed statistically. Results: We found almost similar demographic and clinical characteristics of the women in the two groups, except that more women in the Group P had a systolic blood pressure of 120 to 134 mm Hg when compared to Group A (P = 0.01). We also found a significant difference in weight of women among different groups (P=0.0007). We found the incidence of preeclampsia as 4% and 6% in group A and B respectively. We found almost similar rates of incidence of outcomes like oligohydramnios, premature rupture of the membranes, preterm and post-term delivery, rate of caesarean delivery, average gestational age, birth weight, length at delivery and the number of infants admitted to the neonatal intensive care unit. Conclusion: The incidence of preeclampsia may be reduced by aspirin use among healthy nulliparous pregnant women.


Full Text Attachment

Creative Commons License International Journal of Research in Health Sciences is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License. Based on a work at www.ijrhs.org. Permissions beyond the scope of this license may be available at www.ijrhs.org.

free hit counter